openPR Logo
Press release

Hyperhidrosis Treatment Market Segmentation and Analysis Report, 2027

10-27-2022 01:52 PM CET | Health & Medicine

Press release from: Transparency Market Research

Transparency Market Research (TMR) has published a new report on the global hyperhidrosis treatment market for the forecast period of 2019-2027.

According to the report, the global hyperhidrosis treatment market was valued at ~US$ 1.2 Bn in 2018, and is projected to expand at a CAGR of ~4% from 2019 to 2027. The global market is driven by increase in awareness and acceptance of hyperhidrosis treatment due to the launch of new products and novel treatment options.

The global hyperhidrosis treatment market has been segmented based on treatment type, hyperhidrosis type, end user, and region.

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39308

In terms of treatment type, the global hyperhidrosis treatment market has been classified into botulinum toxin A, iontophoresis, surgical treatments, topical treatments, non-surgical microwave energy destruction of sweat glands, and others.

Based on hyperhidrosis type, the global hyperhidrosis treatment market has been categorized into axillary hyperhidrosis, palmar hyperhidrosis, plantar hyperhidrosis, and others (craniofacial, etc.).

In terms of end user, the global hyperhidrosis treatment market has been divided into hospitals, ambulatory surgical centers, and others (dermatology clinics & cosmetic centers).

Botulinum Toxin A Treatment Type to Lead Market

Sweating control is largely mediated by sympathetic cholinergic pathways, with an adrenergic mechanism having less influence and more associated with sweat odor than volume. Some patients are treated with restricted benefits of anticholinergic therapies such as propantheline, or even topical therapies such as dry-sol.

Botulinum toxin A has emerged as an effective treatment for hyperhidrosis. Hence, the segment is anticipated to dominate the global hyperhidrosis treatment market during the forecast period.

Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=39308

Axillary Hyperhidrosis Segment to Lead Market

Axillary hyperhidrosis (AH) is excessive sweating in the axillae area, and is usually bilateral in pattern. It can be precipitated by heat or mental pressure, and is linked with dermatologic complications, including pompholyx and contact dermatitis.

The prevalence of axillary hyperhidrosis is higher than palmar hyperhidrosis, plantar hyperhidrosis, and others (craniofacial, etc.) hyperhidrosis. Hence, the segment is expected to dominate the global hyperhidrosis treatment market from 2019 to 2027.

Increase in Incidence of Hyperhidrosis across the World to Propel Market

Increase in incidence of hyperhidrosis is correlated with unhealthy diets, sedentary lifestyles, and alcohol consumption that cause multiple disease conditions such as hypoglycemia, anxiety, and hyperthyroidism

Hyperhidrosis is defined as excessive sweating, which happens primarily on the soles, palms, face, and axes, but can also affect the lower limbs, chest, inguinal areas, back, and abdomen.

A study published in the Journal of American Dermatology in 2017 concluded that, the incidence of hyperhidrosis was 2.8% in the U.S. in 2016.

Additionally, rise in research & development spending combined with a rich hyperhidrosis therapy pipeline of leading players is likely to augment the hyperhidrosis treatment market in the near future.

Read Report Overview @ https://www.transparencymarketresearch.com/hyperhidrosis-treatment-market.html

Increase in New Product Launches and Novel Treatment Options to Drive Demand for Hyperhidrosis Treatment

Launch of new products for the treatment of hyperhidrosis is projected to boost the growth of the market during the forecast period.

For instance, Dermira, Inc. announced several updates related to the launch and availability of QBREXZA (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis in adult and pediatric patients.

Moreover, topical treatment (e.g. aluminum chloride) is the first choice for localized hyperhidrosis. Novel treatment options such as iontophoresis, botulinum toxin, non-surgical microwave energy destruction of sweat glands (miraDry), and systemic medications are indicated if topical treatment is insufficient or not applicable. Increase in the availability of these novel treatment options is anticipated to boost demand for hyperhidrosis treatment.

Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=39308

North America a Prominent Hyperhidrosis Treatment Market

North America was the leading market for hyperhidrosis treatment in 2018. Among the major developed countries, the U.S. has the most number of cases of hyperhidrosis. Around 65% of these patients suffer from axillary hyperhidrosis. These factors are expected to fuel the growth of the hyperhidrosis treatment market in the region.

In the U.S., current disease trends indicate that, the number of individuals suffering from various types hyperhidrosis will increase at a rapid pace in the near future.

The rapidly rising population in the U.S. coupled with the rise in obesity is poised to increase the prevalence of hyperhidrosis, which, in turn, will add to the burden of hyperhidrosis treatment on the healthcare system.

Key Players Operating in the Global Hyperhidrosis Treatment Market

The report also provides the profiles of leading players operating in the global hyperhidrosis treatment market. These include GlaxoSmithKline plc, Ulthera, Inc., TheraVida, Dermira, Inc., Revance Therapeutics, Inc., Allergan plc, and Miramar Labs, Inc.

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hyperhidrosis Treatment Market Segmentation and Analysis Report, 2027 here

News-ID: 2780202 • Views:

More Releases from Transparency Market Research

Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 Billion by 2036 at 5.3% CAGR
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B …
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energy
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Application | U.S. • Germany • China • India
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati …
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million to US$ 1,000.2 Million by 2036 at a 17.0% CAGR
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t …
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, and
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported by Biopharma Growth
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b …
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multiple

All 5 Releases


More Releases for Hyperhidrosis

Hyperhidrosis Market Massive Growth opportunity Ahead
Introduction Hyperhidrosis, a condition characterized by excessive sweating beyond physiological needs, affects millions of people worldwide. It often impacts quality of life, causing emotional distress, social withdrawal, and occupational challenges. Primary hyperhidrosis typically involves localized sweating in areas like the palms, soles, and underarms, while secondary hyperhidrosis is linked to systemic conditions or medications. The global hyperhidrosis market has been gaining traction due to rising awareness, increasing diagnosis rates, and advancements in
Major Growth Driver Identified in 2025 Hyperhidrosis Treatment Market: Rising Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts Hyperhidrosis Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for hyperhidrosis treatment has significantly expanded in the latter years. It's projected to rise from $1.58 billion in 2024 to $1.67 billion in 2025, showcasing a compound annual growth rate (CAGR) of
Rising Prevalence Of Diabetes Mellitus Boosts The Hyperhidrosis Treatment Market …
The Hyperhidrosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Hyperhidrosis Treatment Market Size During the Forecast Period? The market size for hyperhidrosis treatment has seen significant growth in recent years. The market value is predicted to increase from $1.58 billion
Leading Element Driving Change in the Hyperhidrosis Treatment Market in 2025: Ri …
What combination of drivers is leading to accelerated growth in the hyperhidrosis treatment market? The hyperhidrosis treatment market is likely to be driven by the growing incidence of diabetes mellitus, a health condition that arises when the body fails to produce sufficient insulin or fails to respond to insulin appropriately, leading to abnormally high blood sugar levels. Diabetes tends to damage the nerves that control sweat glands, resulting in excessive sweating
Major Market Shift in Hyperhidrosis Treatment Industry: Introduction Of Wipe For …
What Is the Forecasted Market Size and Growth Rate for the Hyperhidrosis Treatment Market? The hyperhidrosis treatment market is projected to grow from $1.58 billion in 2024 to $1.67 billion in 2025, at a CAGR of 5.9%. The growth is driven by increasing awareness of the psychosocial impact of hyperhidrosis, cosmetic concerns, and regulatory support. The Hyperhidrosis Treatment market is projected to grow to $2.13 billion by 2029 at a CAGR of
Just Available: Global Axillary Hyperhidrosis Market
MarketResearchReports.Biz presents this most up-to-date research on "Axillary Hyperhidrosis-Pipeline Insights, 2017" Latest Report, Axillary Hyperhidrosis-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Axillary Hyperhidrosis. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing,